Abbott Laboratories (ABT)

$126.85 +0.51 (0.40%)
Market Cap 219.89B
Revenue (ttm) 41.95B
Net Income (ttm) 13.40B
EPS (ttm) N/A
PE Ratio 25.64
Forward PE 24.85
Profit Margin 31.95%
Debt to Equity Ratio 0.26
Volume 5,071,100
Avg Vol 5,749,768
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 22%
Beta 0.69
Analysts Strong Sell
Price Target $146.29

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, North Chicago, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 5:48 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ABT Current Share Price: $126.19 Contracts: $ABT December 18, 2026 $130 Calls Scale in: $12.63- $15.44 Scale out: $19.65-$25.27 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:44 PM
$ABG $ABM $ABNY $ABSI $ABT 10/10 to 10/24 List Results 🔥 Cycle Trading Signal plugged into AI 🔥
0 · Reply
HFlier
HFlier Oct. 24 at 3:56 PM
$ABT WTF is up with this turd. Who did they piss off?
0 · Reply
TpForMyBearHolio
TpForMyBearHolio Oct. 23 at 7:22 PM
$ABT perfect multi-year cup and handle setup. Let’s look for follow through and bounce at either 125 or 120. If it fails 120’ish then down to 110 to fill gap. I’d be looking for confirmation before getting in.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 6:31 PM
$ABT on lows. No participation in the market rally. Puts are about $2.X now.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:40 PM
Sold $ABT puts at $1.00. Quick breakdown to new lows here. Really bad spreads in these though.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:19 PM
Bought the $ABT October 24th $127 puts at $0.70
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:02 PM
$ABT Buyer of the October 24th $128 puts (ITM) 1,000 times for $1.X.26
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 8:54 PM
Enter: $ABT NOV 14 2025 $129 CALLS Buy in Price: $2.05 - $2.33 Take Profit: $4.55 Stop Bleeding: $1.80 ROI Potential: 122% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 22 at 5:03 PM
🚀 New Signal ✅ 🏛️ $ABT 🗓️ Oct 22, 2025 💵 Entry: $128.56 🎯 Target (Opt.): $131.52 (+2.30%) 👉 FREE TRIAL! Check bio.
0 · Reply
Latest News on ABT
Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports

Oct 21, 2025, 7:34 AM EDT - 4 days ago

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports

WMT

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

Oct 18, 2025, 9:39 AM EDT - 6 days ago

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Oct 16, 2025, 12:50 PM EDT - 8 days ago

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Abbott Laboratories Q3 2025 Earnings: Stable Growth Amid Tariff And China Headwinds

Oct 16, 2025, 11:18 AM EDT - 8 days ago

Abbott Laboratories Q3 2025 Earnings: Stable Growth Amid Tariff And China Headwinds

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Oct 15, 2025, 2:20 PM EDT - 9 days ago

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 1:36 PM EDT - 9 days ago

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.

Oct 15, 2025, 8:25 AM EDT - 9 days ago

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.

Abbott Labs Posts Higher Sales, Reaffirms Outlook

Oct 15, 2025, 7:55 AM EDT - 10 days ago

Abbott Labs Posts Higher Sales, Reaffirms Outlook

Abbott posts higher quarterly revenue on strong medical device demand

Oct 15, 2025, 7:36 AM EDT - 10 days ago

Abbott posts higher quarterly revenue on strong medical device demand

Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

Oct 15, 2025, 7:30 AM EDT - 10 days ago

Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'

Oct 15, 2025, 5:59 AM EDT - 10 days ago

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'

BAC MS

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Oct 13, 2025, 10:56 AM EDT - 11 days ago

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)

Oct 9, 2025, 7:37 AM EDT - 16 days ago

Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)

Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors

Oct 6, 2025, 8:00 AM EDT - 18 days ago

Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors

Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 27 days ago

Best Dividend Aristocrats For October 2025

ADP ATO BDX BEN CAH CHRW CL

Abbott Hosts Conference Call for Third-Quarter Earnings

Sep 24, 2025, 9:00 AM EDT - 4 weeks ago

Abbott Hosts Conference Call for Third-Quarter Earnings

These Dividend Stocks Have Big Yields and Are Beating the Odds

Sep 23, 2025, 2:47 PM EDT - 4 weeks ago

These Dividend Stocks Have Big Yields and Are Beating the Odds

ABBV DGRO SDY VIG

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

Sep 19, 2025, 2:25 PM EDT - 5 weeks ago

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

GE KR PM

1 Dividend King To Hold And 2 Worth Buying Now

Sep 19, 2025, 12:37 PM EDT - 5 weeks ago

1 Dividend King To Hold And 2 Worth Buying Now

FRT PPG

Abbott Declares 407th Consecutive Quarterly Dividend

Sep 19, 2025, 9:00 AM EDT - 5 weeks ago

Abbott Declares 407th Consecutive Quarterly Dividend

Inside Abbott's big bet on the future of healthcare

Sep 6, 2025, 9:01 AM EDT - 6 weeks ago

Inside Abbott's big bet on the future of healthcare

Abbott to take $200 million tariff hit: What it means for patients

Sep 3, 2025, 1:30 PM EDT - 7 weeks ago

Abbott to take $200 million tariff hit: What it means for patients

Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis

Aug 29, 2025, 8:00 AM EDT - 2 months ago

Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis

Abbott CEO reveals the biggest disruptions in healthcare

Aug 27, 2025, 2:30 PM EDT - 2 months ago

Abbott CEO reveals the biggest disruptions in healthcare

Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ADM ADP AFL ALB AMCR AOS

Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 2 months ago

Best Dividend Kings: August 2025

ABBV ABM ADM AWR BDX BKH CINF

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

Aug 18, 2025, 9:00 AM EDT - 2 months ago

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

Abbott India's profit climbs on healthy pharmaceutical demand

Aug 12, 2025, 4:18 AM EDT - 2 months ago

Abbott India's profit climbs on healthy pharmaceutical demand

Abbott Laboratories Q2 Earnings: Dividends Don't Lie

Aug 9, 2025, 8:47 AM EDT - 2 months ago

Abbott Laboratories Q2 Earnings: Dividends Don't Lie

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 3 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ALNY AMGN ARGX AZN BAX BIIB

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 3 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ALNY AMGN ARGX AZN BAX BIIB

Best Dividend Aristocrats For August 2025

Jul 28, 2025, 5:19 AM EDT - 3 months ago

Best Dividend Aristocrats For August 2025

BDX BEN

Five years after COVID, pharma shares languish in US policy limbo

Jul 23, 2025, 9:57 AM EDT - 3 months ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ALNY AZN EW LLY MRK NVO

Best Dividend Kings: July 2025

Jul 22, 2025, 9:31 AM EDT - 3 months ago

Best Dividend Kings: July 2025

ABBV ABM ADM ADP AWR BDX BKH

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Jul 18, 2025, 9:03 AM EDT - 3 months ago

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott Laboratories: What's Behind The Q2 Earnings Slump?

Jul 18, 2025, 8:51 AM EDT - 3 months ago

Abbott Laboratories: What's Behind The Q2 Earnings Slump?

Abbott CEO Robert Ford goes one-on-one with Jim Cramer

Jul 17, 2025, 7:56 PM EDT - 3 months ago

Abbott CEO Robert Ford goes one-on-one with Jim Cramer

Didn't see the recovery in China we were expecting, says Abbott Labs CEO on lowering guidance

Jul 17, 2025, 7:55 PM EDT - 3 months ago

Didn't see the recovery in China we were expecting, says Abbott Labs CEO on lowering guidance

Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'

Jul 17, 2025, 7:12 PM EDT - 3 months ago

Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'

Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript

Jul 17, 2025, 2:05 PM EDT - 3 months ago

Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Jul 17, 2025, 8:39 AM EDT - 3 months ago

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

MP

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares.

Jul 17, 2025, 8:16 AM EDT - 3 months ago

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares.

Abbott beats quarterly profit estimates on medical devices demand

Jul 17, 2025, 7:34 AM EDT - 3 months ago

Abbott beats quarterly profit estimates on medical devices demand

Abbott Reports Second-Quarter 2025 Results

Jul 17, 2025, 7:30 AM EDT - 3 months ago

Abbott Reports Second-Quarter 2025 Results

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Jul 16, 2025, 11:43 AM EDT - 3 months ago

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Sell ABT Stock Ahead Of Its Q2 Earnings?

Jul 15, 2025, 7:35 AM EDT - 3 months ago

Sell ABT Stock Ahead Of Its Q2 Earnings?

Should You Buy Abbott Stock At $135?

Jul 9, 2025, 6:35 AM EDT - 3 months ago

Should You Buy Abbott Stock At $135?

Abbott Labs: Proactive, Adaptive, Solid

Jun 30, 2025, 2:02 PM EDT - 4 months ago

Abbott Labs: Proactive, Adaptive, Solid

Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive Momentum

Jun 30, 2025, 2:19 AM EDT - 4 months ago

Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive Momentum

Best Dividend Aristocrats For July 2025

Jun 29, 2025, 7:19 AM EDT - 4 months ago

Best Dividend Aristocrats For July 2025

ABBV ADM ADP AFL ALB AMCR AOS

LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 5:48 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ABT Current Share Price: $126.19 Contracts: $ABT December 18, 2026 $130 Calls Scale in: $12.63- $15.44 Scale out: $19.65-$25.27 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:44 PM
$ABG $ABM $ABNY $ABSI $ABT 10/10 to 10/24 List Results 🔥 Cycle Trading Signal plugged into AI 🔥
0 · Reply
HFlier
HFlier Oct. 24 at 3:56 PM
$ABT WTF is up with this turd. Who did they piss off?
0 · Reply
TpForMyBearHolio
TpForMyBearHolio Oct. 23 at 7:22 PM
$ABT perfect multi-year cup and handle setup. Let’s look for follow through and bounce at either 125 or 120. If it fails 120’ish then down to 110 to fill gap. I’d be looking for confirmation before getting in.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 6:31 PM
$ABT on lows. No participation in the market rally. Puts are about $2.X now.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:40 PM
Sold $ABT puts at $1.00. Quick breakdown to new lows here. Really bad spreads in these though.
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:19 PM
Bought the $ABT October 24th $127 puts at $0.70
0 · Reply
OptionRunners
OptionRunners Oct. 23 at 3:02 PM
$ABT Buyer of the October 24th $128 puts (ITM) 1,000 times for $1.X.26
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 8:54 PM
Enter: $ABT NOV 14 2025 $129 CALLS Buy in Price: $2.05 - $2.33 Take Profit: $4.55 Stop Bleeding: $1.80 ROI Potential: 122% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 22 at 5:03 PM
🚀 New Signal ✅ 🏛️ $ABT 🗓️ Oct 22, 2025 💵 Entry: $128.56 🎯 Target (Opt.): $131.52 (+2.30%) 👉 FREE TRIAL! Check bio.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 22 at 1:15 PM
$ABT RSI: 35.60, MACD: -0.9933 Vol: 2.04, MA20: 131.71, MA50: 131.73 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 8:07 PM
Enter: $ABT NOV 14 2025 $129 CALLS Buy in Price: $2.24 - $2.41 Take Profit: $3.45 Stop Bleeding: $2.12 ROI Potential: 43% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
TalkMarkets
TalkMarkets Oct. 21 at 5:50 PM
3 Wealth-Building #Dividend Growth Stocks For The Long Run $ABT $BDX $GWW https://talkmarkets.com/content/stocks--equities/3-wealth-building-dividend-growth-stocks-for-the-long-run?post=529612
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 7:20 AM
Enter: $ABT NOV 14 2025 $130 CALLS Buy in Price: $2.53 - $2.66 Take Profit: $4.33 Stop Bleeding: $2.23 ROI Potential: 71% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 21 at 3:48 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ABT Current Share Price: $128.54 Contracts: $ABT December 18, 2026 $130 Calls Scale in: $12.98- $15.87 Scale out: $20.20-$25.97 Can Easily Capture: 60% ROI Blended DTE: 425 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 20 at 11:44 PM
$ABT Share Price: $129.51 Contract Selected: Nov 14, 2025 $130 Calls Buy Zone: $1.93 – $2.38 Target Zone: $3.53 – $4.31 Potential Upside: 73% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 8:31 PM
Enter: $ABT NOV 14 2025 $130 CALLS Buy in Price: $2.53 - $2.82 Take Profit: $4.38 Stop Bleeding: $2.23 ROI Potential: 73% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 20 at 1:54 PM
$ABT delivered strong Q3 growth — but can it keep the pace? Tariff headwinds and softness in Diagnostics are clouding what was otherwise a solid quarter across key segments. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2772221/abbott-q3-earnings-review-tariff-diagnostics-cap-near-term-gains?cid=sm-stocktwits-2-2772221-teaser-16775&ADID=SYND_STOCKTWITS_TWEET_2_2772221_TEASER_16775
0 · Reply
ZacksResearch
ZacksResearch Oct. 20 at 12:54 PM
Abbott’s Q3: Earnings and Revenue Growth, But Why the Tepid Market Reaction? 🤔 Despite a solid Q3 with earnings in line with expectations and revenue miss, $ABT's shares lagged behind rivals like Boston Scientific and Medtronic. Tariffs and concerns over ABT's stretched valuation compared to peers are capping enthusiasm. 📉 See the full breakdown here 👉 https://www.zacks.com/stock/news/2772221/abbott-q3-earnings-review-tariff-diagnostics-cap-near-term-gains?cid=sm-stocktwits-2-2772221-body-16760&ADID=SYND_STOCKTWITS_TWEET_2_2772221_BODY_16760
0 · Reply
chatGPTguy
chatGPTguy Oct. 20 at 4:08 AM
$ABT
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 6:34 PM
Enter: $ABT NOV 14 2025 $130 CALLS Buy in Price: $2.20 - $2.50 Take Profit: $4.47 Stop Bleeding: $1.94 ROI Potential: 103% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
TalkMarkets
TalkMarkets Oct. 19 at 12:53 PM
#Earnings And #Volatility Will Lead To Ideal Setups $ABT $BRO $QQQ $AMZN $NFLX https://talkmarkets.com/content/us-markets/earnings-and-volatility-will-lead-to-ideal-setups?post=529327
0 · Reply